Dermatophagoides Antigens
36
relevant articles (1 outcomes,
5 trials/studies)
found for this Bio-Agent
Description:
Antigens from the house dust mites (DERMATOPHAGOIDES), mainly D. farinae and D. pteronyssinus. They are proteins, found in mite feces or mite extracts, that can cause ASTHMA and other allergic diseases such as perennial rhinitis (RHINITIS, ALLERGIC, PERENNIAL) and atopic dermatitis (DERMATITIS, ATOPIC). More than 11 groups of Dermatophagoides ALLERGENS have been defined. Group I allergens, such as Der f I and Der p I from the above two species, are among the strongest mite immunogens in humans.
Also Known As:
Antigens, Dermatophagoides; Allergens, House Dust Mites; Antigens, House Dust Mites; Dermatophagoides Allergens; Dermatophagoides farinae Allergens; Dermatophagoides pteronyssinus Allergens; Norisen; Pharmalgen; Allergens, Dermatophagoides; Allergens, Dermatophagoides farinae; Allergens, Dermatophagoides pteronyssinus; Dermatophagoides farinae Antigens; Dermatophagoides pteronyssinus Antigens; Antigens, Dermatophagoides farinae; Antigens, Dermatophagoides pteronyssinus
Relationship Network
Bio-Agent Context: Research Results
Experts
Related Diseases
| 1. | Asthma (Bronchial Asthma)
|
| 2. | Rhinitis
01/01/2003
- " Its clinical efficacy (improvement of symptoms and reduction of drug intake) for both asthma and rhinitis has been assessed in detail for the most common allergens: house dust mites, grass pollen, Parietaria, birch pollen and olive tree. " 05/01/1989
- " Two control groups were studied: 28 subjects with allergic rhinitis, with or without asthma, receiving placebo injections for 1 yr in a double-blind controlled trial with Pharmalgen D. " 04/01/1992
- " pteronyssinus) immunotherapy for allergic rhinitis, comparing two active treatments, Pharmalgen and Allpyral, with placebo. " 05/01/1989
- " Changes in the level of serum neutrophil chemotactic activity (S-NCA) were investigated in 20 subjects with allergic rhinitis, with or without asthma, undergoing clinically effective hyposensitization to house dust mite with Pharmalgen Dermatophagoides pteronyssinus. " 05/01/2003
- " Accordingly, we have investigated the immunoregulatory mechanism of both normal and allergic responses to the major house-dust mite (HDM) and birch pollen allergens--Dermatophagoides pteroynyssinus (Der p)1 and Bet v 1, respectively--as well as the immunologic basis of SIT to HDM in rhinitis and asthma patients. "
Order ALL the reference details at left...
|
| 3. | Multiple Sclerosis
|
| 4. | Atopic Dermatitis (Atopic Eczema)
|
| 5. | Hypersensitivity (Allergy)
01/01/2004
- " Atopy in child was defined on the basis of occurrence of symptoms of allergy to at least one of the following allergens: house dust mites, animal dander, pollens or symptoms of food allergy confirmed by physician's diagnosis. " 01/01/2003
- " We analyzed the data of 241 patients with known allergy to hymenoptera venom (208 sensitive to Apis mellifera and 33 to Vespula spp.), who were treated with ITV (Pharmalgen, ALK-ABELLO) for an average period of 32 months. " 06/15/1991
- " Recently, a new immunoenzymatic test (Allergy Screen Profile, ASP) has been proposed for the simultaneous determination of IgE specific for five inhaled allergens (Dermatophagoides, animal dander, trees, grass pollen and Parietaria). " 11/01/1989
- " A new skin test method (Phazet) for diagnosis of immediate-type allergic disease was tested in 232 patients attending the Guy's Hospital Allergy Clinic, and compared with conventional skin test methods, using Bencard and Pharmalgen allergen solutions, and with serum IgE antibody tests (RAST). " 01/01/1994
- " The intensity of reaction in the CAP-Phadiatop assay was highly correlated with: (1) an allergy index (p < 0.005), based on skin prick test reactivity to seven relevant inhalant allergens (Dermatophagoides pteronyssinus, mixed grass pollens, cat epithelium, Parietaria judaica, Olea europaea, Artemisia vulgaris, Alternaria tenuis); (2) the concentration of specific IgE to the same allergens, measured by CAP-RAST (p < 0.001), in both monosensitized and polysensitized subjects; (3) the rate of respiratory allergic diseases (p < 0.0001). "
Order ALL the reference details at left...
|
|
Related Drugs and Biologics
Related Therapies and Procedures